Evidence map›Paper›PMID 32924072›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2020

Development of an improved Amplex Red peroxidation activity assay for screening cytochrome P450 variants and identification of a novel mutant of the thermophilic CYP119.

M Semih Başlar, Tuğçe Sakallı, Gülce Güralp, Ekin Kestevur Doğru, Emre Haklı, Nur Basak Surmeli

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Advances in the Directed Evolution of Computer-aided Enzymes.Current topics in medicinal chemistry · 2025
    Review
  3. Nanoparticles for cancer therapy: a review of influencing factors and evaluation methods for biosafety.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  4. Evolution of Cytochrome P450 Enzymes and Their Redox Partners in Archaea.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

M Semih BaşlarDepartment of Bioengineering, İzmir Institute of Technology, Gülbahçe, Urla, Izmir, Turkey.
Tuğçe SakallıProgram in Biotechnology and Bioengineering, İzmir Institute of Technology, Gülbahce, Urla, Izmir, Turkey.
Gülce GüralpDepartment of Bioengineering, İzmir Institute of Technology, Gülbahçe, Urla, Izmir, Turkey.
Ekin Kestevur DoğruDepartment of Bioengineering, İzmir Institute of Technology, Gülbahçe, Urla, Izmir, Turkey.
Emre HaklıProgram in Biotechnology and Bioengineering, İzmir Institute of Technology, Gülbahce, Urla, Izmir, Turkey.
Nur Basak SurmeliDepartment of Bioengineering, İzmir Institute of Technology, Gülbahçe, Urla, Izmir, Turkey. nursurmeli@iyte.edu.tr.
Izmir Institute of Technology · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biocatalysts are increasingly utilized in the synthesis of drugs and agrochemicals as an alternative to chemical catalysis. They are preferred in the synthesis of enantiopure products due to their high regioselectivity and enantioselectivity. Cytochrome P450 (P450) oxygenases are valuable biocatalysts, since they catalyze the oxidation of carbon-hydrogen bonds with high efficiency and selectivity. However, practical use of P450s is limited due to their need for expensive cofactors and electron transport partners. P450s can employ hydrogen peroxide (H

Indexed as

MutationArchaeal ProteinsCatalytic DomainCytochrome P-450 Enzyme SystemHemeHydrogen PeroxideOxazinesOxidation-ReductionAmplex RedArchaeal ProteinsCYP119 protein, Sulfolobus solfataricusCytochrome P-450 Enzyme SystemHemeHydrogen PeroxideOxazinesBiocatalysisCytochromeEnzyme kineticsHemeProtein engineering

Identifiers

PMID32924072
OpenAlexW3086312631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.